ROME – Target IOP is a complex, dynamic concept that requires knowledge, clinical intelligence and constant updating to become an effective therapeutic means, according to a presentation here. “It is ...
Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...
The patient characteristics and ocular data are shown in Table 1. The average preoperative IOP was 18.5±5.5 mm Hg. Medication was used on 29 eyes (44%) after the operation. The number of glaucoma ...
To investigate the comparative efficacy and safety of deep sclerectomy with and without intraoperative mitomycin C (MMC) application for lowering the intraocular pressure (IOP). A total of 71 eyes of ...
CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...
Perhaps one of the most exciting new areas of study is the field of neuroprotection, where researchers are investigating the effects of blood flow in and around the optic nerve head and the health of ...
The purpose of this exceptional review was to examine any impact on the NICE guideline following the publication of a Health Technology Assessment (HTA) report on Selective laser trabeculoplasty ...
IRVINE, Calif. - Allergan today announced that the U.S. Food and Drug Administration has approved COMBIGAN™ (brimonidine tartrate/timolol maleate ophthalmic ...
The purpose of this exceptional review was to examine any impact on the NICE guideline following the publication of a Health Technology Assessment (HTA) report on Selective laser trabeculoplasty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback